Patent · US Active

Identifying patients at risk for life threatening arrhythmias

US7608458B2 · kind B2 · utility

35Cited by

14References

25Claims

0Family size

Assignee

Medtronic, Inc. · US

Inventors

Orhan Soykan · Shoreview, US
Amy C. Dearking · Rochester, US
Timothy H. Robinson · Savage, US
Walter H. Olson · North Oaks, US
Vinod Sharma · Bengaluru, IN

Key dates

Filing date	Jun 21, 2005
Grant date	Oct 27, 2009
Priority date	—
Expiry date	Oct 11, 2027

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/326
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention is a method for identifying proteins associated with sudden cardiac death (SCD) and for assessing a patient's risk of SCD by determining the amount of one or more SCD-associated proteins in the patient. Typically, the patient submits a sample, such as a blood sample, which is tested for one or more SCD-associated proteins. Based upon the results of the tests, the patient's risk of SCD may be assessed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.